
Nuwellis Inc
NUWE · NASDAQ · Healthcare / Medical Devices
4.90USD-0.13 (-2.58%)
Price History
Full chartMarket Stats
Previous Close5.03
Open5.05
Day Range4.79 – 5.27
52-Week Range0.71 – 172.90
Volume21.94K
Market Cap2.46M
P/E (TTM)0.00
Forward P/E0.00
EPS2,548.34
Dividend Yield0.00%
Beta0.23
50-Day Avg1.43
200-Day Avg36.09
About
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Company Details
- SectorHealthcare
- IndustryMedical Devices
- CEOMr. Michael Kendrick McCormick
- Employees38
- Headquarters12988 Valley View Road, Eden Prairie, MN, United States, 55344, USA
- Websitehttps://www.nuwellis.com
Leadership
- Mr. Michael Kendrick McCormickPresident, CEO & Director · b. 1962
- Mr. Neil P. Ayotte Esq.Senior VP, General Counsel, Secretary & Chief Compliance Officer · b. 1963
- Ms. Carisa SchultzCFO, Principal Financial Officer & Principal Accounting Officer · b. 1978
- Ms. Kim AndersonVice President, Research & Development, Quality and Operations
- Mr. David LernerChief Technology Officer
- Leah McMullenDirector of Communications
- Mr. Paul WottaCorporate Controller · b. 1958
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap2.46M
Enterprise Value-1.04M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.27
Price / Book0.18
EPS2,548.34
Book Value-3.58
Revenue (TTM)9.01M
Gross Profit (TTM)6.28M
EBITDA-12.72M
Profit Margin-125.63%
Operating Margin-160.95%
Return on Equity-609.44%
Return on Assets-87.83%
Shares Outstanding3.18M
Shares Float3.45M
Beta0.23
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%
Analyst Ratings
Buy
Based on 1 analystsTarget 11.00
- Buy1
Ownership Breakdown
- Institutions
- 2.59%
- Insiders
- 4.96%
- Retail / Other
- 92.45%
Top Institutional Holders
- Armistice Capital, LLC236.20K1.85%
- Geode Capital Management, LLC44.18K0.35%
- Tower Research Capital LLC5.19K0.04%
- Citigroup Inc5.13K0.04%
- SBI Securities Co Ltd630.00%
- UBS Group AG460.00%
- Caitong International Asset Management Co., Limited.40.00%
- Ankerstar Wealth, LLC10.00%
- DRW Securities, LLC00.00%
- Sabby Management LLC00.00%
- XTX Topco Ltd00.00%
- Bank of America Corp00.00%
Top Fund Holders
- Fidelity Extended Market Index6090.02%
- Fidelity Series Total Market Index420.00%
Stock Splits
- Oct 27, 20261:9
- Jun 26, 20261:35
- Jul 7, 20251:42
- Jun 28, 20241:35
- Dec 12, 20221:100
- Oct 19, 20201:30
- Jan 3, 20191:14
- Oct 13, 20171:20
- Jan 13, 20171:30